SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is surging following reports that the company plans to launch a cloud-computing business to monetize its excess AI computing power. While this has sparked optimism regarding Meta's ability to drive revenue from its massive infrastructure spending, it has triggered volatility in neocloud and semiconductor stocks as investors reassess future supply and competitive dynamics in the AI hardware sector.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending downward following reports that Meta may enter the AI cloud infrastructure market by monetizing its excess compute capacity, sparking investor concerns over potential increased competition and pricing pressure. While the market reaction has been swift, community discussions remain divided between those viewing the news as an overblown fear tactic and others who argue the shift signals a structural threat to the neocloud business model.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy is currently facing heightened volatility as investors weigh the impact of an accelerated share offering alongside the company's critical role in meeting AI-driven electricity demand. Community sentiment remains largely bullish on the long-term potential of the nuclear fleet to power data centers, with many traders actively viewing the current price dip as an opportunity to average down despite short-term regulatory and supply chain concerns.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending due to significant retail interest in a potential short squeeze, fueled by its low float and high short interest compared to sector peers. The community is actively debating the stock's turnaround potential and comparing it to other high-volatility meme plays, while investors monitor for upward momentum following recent debt refinancing initiatives.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant momentum and renewed interest as investors pivot toward its expanding pipeline of oncology and rare disease treatments, bolstered by positive FDA briefing documents for its mRNA flu vaccine candidate. The community is actively debating the stock's potential for a short squeeze and long-term re-rating, closely monitoring institutional accumulation and upcoming investor events.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Natural gas traders are actively debating a potential short squeeze as speculative interest surges alongside forecasts for widespread heatwaves and tightening supply storage levels. The conversation remains highly polarized between bullish sentiment driven by rising energy demand and skepticism from those wary of the fund's historical decay and recurring reverse splits.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending due to reports that its advanced manufacturing capacity remains structurally constrained despite aggressive capital expenditure, fueling sustained AI-driven demand and institutional focus on its pricing power. The community is actively debating the company's long-term dominance in the semiconductor supply chain and assessing how its critical role in advanced node fabrication and packaging influences global AI investment cycles.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is currently trending as community members closely monitor a potential short squeeze, given the high short interest and growing speculation regarding its strategic value as a global telehealth leader. Investors are actively debating the company's long-term potential fueled by recent retail partnerships, international expansion, and the ongoing integration of AI into its healthcare platform.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as investors react to its Investor Day, where the company announced a significant strategic shift toward data center AI, including supply agreements with Meta and Microsoft. Despite these major hyperscaler partnerships and long-term revenue growth targets, the stock has faced downward pressure due to a broader semiconductor sell-off and market skepticism regarding the timeline for these infrastructure contributions.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is driving market conversation following a definitive agreement to acquire Terns Pharmaceuticals for $6.7 billion, a strategic move to bolster its oncology pipeline ahead of the looming Keytruda patent cliff. Investors are now actively debating whether this signals a broader M&A frenzy, with community sentiment split between those praising the premium deal and those speculating on which high-potential biotech might be the next buyout target.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health

Hims & Hers leads three healthcare IT stocks up over 20% in 2025, as digital care, remote monitoring and data platforms gain traction.

3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run

Three Healthcare IT stocks have surged over 20% in 2025, driven by growth in telehealth, remote monitoring and value-based care platforms.

Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates

Biotricity (BTCY) delivered earnings and revenue surprises of +62.50% and -0.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates

Fate Therapeutics (FATE) delivered earnings and revenue surprises of +6.90% and +104.82%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates

Pulmonx (LUNG) delivered earnings and revenue surprises of +15.00% and +4.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates

Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +158.33% and +3.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of +18.42% and +6.81%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

iRhythm Technologies (IRTC) Reports Q3 Loss, Beats Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of +83.33% and +4.97%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Are Medical Stocks Lagging  Biotricity (BTCY) This Year?

Here is how Biotricity Inc. (BTCY) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Biotricity (BTCY) Upgraded to Buy: Here's Why

Biotricity (BTCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. Its products include Bioflux, Biocore, Bioheart, Biokit, and Biocare. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on January 25, 2011 and is headquartered in Redwood City, CA.

Biotricity Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BTCYBiotricity Inc

Upcoming Earnings:

Historical Earnings

Latest BTCY News